Focus Stocks
Walgreen Expecting Resistance Soon?
Published on Wednesday, 08 February 2012 05:28 Written by TradersHuddle Wire
New York, February 8th (TradersHuddle.com) - Shares of Walgreen Company (NYSE:WAG) closed the trading session at $33.46 near its 50 day moving average currently set at $33.62. Walgreen's price action is below this important level, which makes the stock difficult to buy, as there will certainly be resistance as it approaches its 50 day.
Walgreen Company (NYSE:WAG) operates retail drugstores that offer a wide variety of prescription and non-prescription drugs as well as general merchandise. The Company operates stores throughout the United States. the company also offers health services, including primary and acute care, wellness, pharmacy and disease management services.
Latest price action range, defined by a peaks and troughs algorithm places calculated support at $33.00 and calculated resistance at $35.35. These levels will be closely watched by traders, as they provide great insight into the latest price dynamics defined by Walgreen shares.
Traders should evaluate their trade if they want to establish a position on Walgreen given the resistance expected as the stock approaches the 50 day moving average. A trade might materialize as the stock manages to break this important level, as it could be used as support going forward, however until the break materializes buying the stock is nothing different than flipping a coin. Other levels that traders will be evaluating are the ones defined by the peak and troughs algorithm that provides great price level reference points.
Related Articles
- Approaching Support: Walgreen
- Walgreens Launches New and Improved Prescription Savings Club as Approximately 1 in 4 U.S. Adults Lack Adequate Prescription Drug Coverage
- Trading Idea: What to Expect with Walgreen Breaking Support
- Near Key Levels: Walgreen
- Walgreen Is in a Tight Range between the 50 and 200 Day Moving Averages
- Walgreens Selects GSD&M as Creative Agency of Record
- Walgreen near Support
- Walgreens Offering Pertussis (Whooping Cough) Vaccine at its 129 Locations Statewide as Washington State Reaches Epidemic Levels
- Walgreen Is Approaching Important Moving Averages
- Walgreens Completes Acquisition of BioScrip's Community Specialty Pharmacies and Centralized Specialty and Mail Service Pharmacy Businesses
Related Partner Headlines
- Walgreen Stock To Go Ex-dividend Tomorrow (WAG) - TheStreet.com
- Getting Defensive With Walgreen and Teva - TheStreet.com
- A Checkup on Two Health Care Stocks - TheStreet.com
- Walgreen Company (WAG): Today's Featured Retail Winner - TheStreet.com
- Walgreens April Comparable Store Front-End Sales Decrease 2.2% - Benzinga
- Walgreen Company (WAG): Today's Featured Retail Loser - TheStreet.com
- Express Scripts-Medco Deal: Impact on Walgreen Stock - TheStreet.com
- The Day Ahead: Stay Skeptical - TheStreet.com
- This Oddly Misery-Inducing Market - TheStreet.com
- A Successful Italian Job - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Coming Week: Top Nine Earnings on Deck - TheStreet.com -
Something's Not Right in the Video-Game Space - TheStreet.com -
For Ambitious Students, Entrepreneurship Can Be a Big Win - TheStreet.com -
Stock Futures Rise on Eurobond Talk - TheStreet.com -
You Can Let Your Guard Down: Ask Noah - TheStreet.com -
Apple Strengthens Its Supply Chain - TheStreet.com -
NYSE Is Winning the IPO Listing War - TheStreet.com -
Toyota Is Back as May Sales Continue Auto Industry Recovery - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:▲1.82 (0.14%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:▼10.74 (-0.38%)In The Wires
-
Vertex Receives European CHMP Positive Opinion for KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis -
SunOpta Enters Into Agreement to Divest Its Canadian Based Natural Health Products Business -
PC Connection, Inc. (PCCC) To Present at The SeeThruEquity First Annual Small Cap Investor Conference on Tuesday, June 5, 2012 -
Aeroflex Announces Amendment to Credit Agreement -
Alliance Data to Participate at Upcoming Investor Conferences -
PCA3 Test Featured at American Urological Association Meeting -
MOCON Announces Quarterly Dividend -
Government of Rwanda Introduces Merck's ROTATEQ® (Rotavirus Vaccine, Live, Oral, Pentavalent) to Help Protect Children Against Rotavirus









